Argen-X (ARGX)

250.80
-6.20(-2.41%)
  • Volume:
    72,729
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    247.40 - 257.10
  • Type:Equity
  • Market:Belgium
  • ISIN:NL0010832176

ARGX Overview

Prev. Close
257
Day's Range
247.4-257.1
Revenue
565.61M
Open
257.1
52 wk Range
201.4-320
EPS
-6.14
Volume
72,729
Market Cap
12.96B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
65,869
P/E Ratio
-
Beta
0.65
1-Year Change
11.06%
Shares Outstanding
51,668,315
Next Earnings Date
02 Mar 2022
What is your sentiment on Argen-X?
or
Market is currently closed. Voting is open during market hours.

Argen-X Company Profile

Employees
336
Market
Belgium

argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor such as cell proliferation and survival; ARGX-111, an antagonist of c-Met, a receptor tyrosine kinase involved in cell proliferation, angiogenesis and metastasis in multiple solid tumors; ARGX-112, an antigen which targets atopic dermatitis by neutralization of IL-20 and IL-22 (interleukin) mediated signaling through blockade of their common receptor, among others.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellBuy
Technical IndicatorsStrong SellSellStrong SellStrong SellStrong Buy
SummaryStrong SellStrong SellStrong SellStrong SellStrong Buy
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.